vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and G III APPAREL GROUP LTD (GIII). Click either name above to swap in a different company.
G III APPAREL GROUP LTD is the larger business by last-quarter revenue ($988.6M vs $829.0M, roughly 1.2× Acadia Healthcare Company, Inc.). G III APPAREL GROUP LTD runs the higher net margin — 8.2% vs 0.5%, a 7.6% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -9.0%). Over the past eight quarters, G III APPAREL GROUP LTD's revenue compounded faster (13.7% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
G III Apparel Group is a global fashion company that designs, sources, manufactures, markets and distributes apparel, footwear, and accessories under a range of owned and licensed well-known brands. It serves department stores, specialty retailers, and e-commerce platforms across North America, Europe, and other key global markets, catering to casual, sportswear, and premium fashion consumer segments.
ACHC vs GIII — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $988.6M |
| Net Profit | $4.5M | $80.6M |
| Gross Margin | — | 38.6% |
| Operating Margin | — | 11.4% |
| Net Margin | 0.5% | 8.2% |
| Revenue YoY | 7.5% | -9.0% |
| Net Profit YoY | -50.8% | -29.8% |
| EPS (diluted) | $0.05 | $1.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $988.6M | ||
| Q3 25 | $851.6M | $613.3M | ||
| Q2 25 | $869.2M | $583.6M | ||
| Q1 25 | $770.5M | $839.5M | ||
| Q4 24 | $774.2M | $1.1B | ||
| Q3 24 | $815.6M | $644.8M | ||
| Q2 24 | $796.0M | $609.7M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $80.6M | ||
| Q3 25 | $36.2M | $10.9M | ||
| Q2 25 | $30.1M | $7.8M | ||
| Q1 25 | $8.4M | $48.8M | ||
| Q4 24 | $32.6M | $114.8M | ||
| Q3 24 | $68.1M | $24.2M | ||
| Q2 24 | $78.5M | $5.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 40.8% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | — | 39.5% | ||
| Q4 24 | — | 39.8% | ||
| Q3 24 | — | 42.8% | ||
| Q2 24 | — | 42.5% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 11.4% | ||
| Q3 25 | 4.7% | 2.7% | ||
| Q2 25 | 5.8% | 1.5% | ||
| Q1 25 | 1.7% | 8.5% | ||
| Q4 24 | 4.9% | 15.3% | ||
| Q3 24 | 12.1% | 6.4% | ||
| Q2 24 | 13.4% | 2.2% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 8.2% | ||
| Q3 25 | 4.3% | 1.8% | ||
| Q2 25 | 3.5% | 1.3% | ||
| Q1 25 | 1.1% | 5.8% | ||
| Q4 24 | 4.2% | 10.6% | ||
| Q3 24 | 8.4% | 3.8% | ||
| Q2 24 | 9.9% | 1.0% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.84 | ||
| Q3 25 | $0.40 | $0.25 | ||
| Q2 25 | $0.33 | $0.17 | ||
| Q1 25 | $0.09 | $1.00 | ||
| Q4 24 | $0.36 | $2.55 | ||
| Q3 24 | $0.74 | $0.53 | ||
| Q2 24 | $0.85 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $184.1M |
| Total DebtLower is stronger | $2.5B | $6.5M |
| Stockholders' EquityBook value | $2.0B | $1.8B |
| Total Assets | $5.5B | $2.8B |
| Debt / EquityLower = less leverage | 1.29× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $184.1M | ||
| Q3 25 | $118.7M | $301.8M | ||
| Q2 25 | $131.4M | $257.8M | ||
| Q1 25 | $91.2M | $181.4M | ||
| Q4 24 | $76.3M | $104.7M | ||
| Q3 24 | $82.1M | $414.8M | ||
| Q2 24 | $77.2M | $508.4M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $6.5M | ||
| Q3 25 | $2.3B | $6.9M | ||
| Q2 25 | $2.3B | $6.8M | ||
| Q1 25 | $2.2B | $3.0M | ||
| Q4 24 | $2.0B | $213.9M | ||
| Q3 24 | $1.9B | $402.5M | ||
| Q2 24 | $1.8B | $402.7M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $1.8B | ||
| Q3 25 | $3.1B | $1.7B | ||
| Q2 25 | $3.1B | $1.7B | ||
| Q1 25 | $3.0B | $1.7B | ||
| Q4 24 | $3.1B | $1.6B | ||
| Q3 24 | $3.0B | $1.5B | ||
| Q2 24 | $3.0B | $1.5B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.8B | ||
| Q3 25 | $6.4B | $2.7B | ||
| Q2 25 | $6.3B | $2.4B | ||
| Q1 25 | $6.1B | $2.5B | ||
| Q4 24 | $6.0B | $2.8B | ||
| Q3 24 | $5.9B | $2.7B | ||
| Q2 24 | $5.7B | $2.6B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.00× | ||
| Q3 25 | 0.74× | 0.00× | ||
| Q2 25 | 0.74× | 0.00× | ||
| Q1 25 | 0.72× | 0.00× | ||
| Q4 24 | 0.64× | 0.13× | ||
| Q3 24 | 0.62× | 0.27× | ||
| Q2 24 | 0.62× | 0.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $-97.3M |
| Free Cash FlowOCF − Capex | — | $-106.4M |
| FCF MarginFCF / Revenue | — | -10.8% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | 13.78× | -1.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $367.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $-97.3M | ||
| Q3 25 | $73.2M | $75.1M | ||
| Q2 25 | $133.5M | $93.8M | ||
| Q1 25 | $11.5M | $333.4M | ||
| Q4 24 | $116.7M | $-111.8M | ||
| Q3 24 | $163.1M | $49.3M | ||
| Q2 24 | $171.1M | $45.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $-106.4M | ||
| Q3 25 | $-63.0M | $64.7M | ||
| Q2 25 | $-34.2M | $85.7M | ||
| Q1 25 | $-163.2M | $323.7M | ||
| Q4 24 | $-86.8M | $-120.3M | ||
| Q3 24 | $-27.1M | $38.8M | ||
| Q2 24 | $16.9M | $32.8M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | -10.8% | ||
| Q3 25 | -7.4% | 10.6% | ||
| Q2 25 | -3.9% | 14.7% | ||
| Q1 25 | -21.2% | 38.6% | ||
| Q4 24 | -11.2% | -11.1% | ||
| Q3 24 | -3.3% | 6.0% | ||
| Q2 24 | 2.1% | 5.4% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.9% | ||
| Q3 25 | 16.0% | 1.7% | ||
| Q2 25 | 19.3% | 1.4% | ||
| Q1 25 | 22.7% | 1.2% | ||
| Q4 24 | 26.3% | 0.8% | ||
| Q3 24 | 23.3% | 1.6% | ||
| Q2 24 | 19.4% | 2.1% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | -1.21× | ||
| Q3 25 | 2.02× | 6.86× | ||
| Q2 25 | 4.43× | 12.09× | ||
| Q1 25 | 1.37× | 6.83× | ||
| Q4 24 | 3.58× | -0.97× | ||
| Q3 24 | 2.39× | 2.04× | ||
| Q2 24 | 2.18× | 7.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
GIII
| Proprietary Brands | $498.1M | 50% |
| Licensed Brands | $479.2M | 48% |
| Retail Segment | $45.7M | 5% |
